A detailed history of Advisor Net Financial, Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Advisor Net Financial, Inc holds 84 shares of PCRX stock, worth $1,635. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84
Previous 33 154.55%
Holding current value
$1,635
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$11.7 - $28.46 $596 - $1,451
51 Added 154.55%
84 $1,000
Q1 2024

Apr 12, 2024

SELL
$27.7 - $35.48 $193 - $248
-7 Reduced 17.5%
33 $0
Q3 2023

Oct 12, 2023

BUY
$30.68 - $40.09 $1,043 - $1,363
34 Added 566.67%
40 $1,000
Q2 2023

Jul 14, 2023

SELL
$36.12 - $47.5 $36 - $47
-1 Reduced 14.29%
6 $0
Q1 2023

Apr 28, 2023

BUY
$35.53 - $43.38 $248 - $303
7 New
7 $0
Q2 2020

Aug 26, 2020

SELL
$30.8 - $52.47 $26,180 - $44,599
-850 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$28.4 - $50.7 $24,140 - $43,095
850 New
850 $29,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.